Axogen (AXGN) Cash from Financing Activities (2010 - 2026)

Axogen's (AXGN) quarterly Cash from Financing Activities came in at $59.5 million in Q1 2026, up 2398.11% year-on-year from $2.4 million in Q1 2025, and up 1203.22% quarter-over-quarter from $4.6 million in Q4 2025.

Axogen (AXGN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Axogen's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $59.5 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 2398.11% year-over-year to $59.5 million in Q1 2026; TTM through Mar 2026 was $67.6 million, a 1413.47% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 358.47% from the prior year.
  • Cash from Financing Activities climbed to $59.5 million in Q1 2026 per AXGN's latest filing, from $4.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $59.5 million in Q1 2026 and bottomed at $5000.0 in Q3 2023.
  • The 5-year median for Cash from Financing Activities is $671000.0 (2022), against an average of $4.5 million.
  • Across the five-year window, Cash from Financing Activities slumped 97.67% in 2023 and jumped 11340.0% in 2024, its largest moves.
  • Year by year, Cash from Financing Activities stood at $813000.0 in 2022, then tumbled by 48.59% to $418000.0 in 2023, then soared by 132.06% to $970000.0 in 2024, then jumped by 370.72% to $4.6 million in 2025, then soared by 1203.22% to $59.5 million in 2026.
  • Per Business Quant, the three latest AXGN Cash from Financing Activities figures stand at $59.5 million (Q1 2026), $4.6 million (Q4 2025), and $2.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Axogen 2.05 Bn 1.95 Bn 46.19 Mn 59.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.51 Mn
Mar 31, 2026 59.51 Mn
Dec 31, 2025 4.57 Mn
Dec 31, 2025 4.57 Mn
Sep 30, 2025 2.39 Mn
Sep 30, 2025 2.39 Mn
Jun 30, 2025 1.16 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 2.38 Mn
Mar 31, 2025 2.38 Mn
Dec 31, 2024 970,000.00
Dec 31, 2024 970,000.00
Sep 30, 2024 572,000.00
Sep 30, 2024 572,000.00
Jun 30, 2024 544,000.00
Jun 30, 2024 544,000.00
Mar 31, 2024 204,000.00
Mar 31, 2024 204,000.00
Dec 31, 2023 418,000.00
Dec 31, 2023 418,000.00